Fresenius Medical Care Sees U.S. Plans for Kidney Disease as Positive
As a health professional, you need the leading dialysis products, renal pharmaceuticals and critical care solutions. Let's work together to find you the tools you need, so you can deliver the best care for patients.
Power your practice with our resources. We're here to help support your patients and your thriving practice.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
Success! The link has been copied to your clipboard.
Nationwide, more than 400,000 Americans have kidney disease so bad that they need regular dialysis – meaning they have to connect to a machine for several hours at least three times a week to clean their blood of toxins.
“They have to come at a certain time, so it’s very scheduled, very regimented, and their time is not their own,” says Dr. Robert LaClair, a nephrologist, or kidney specialist at St. Peter’s hospital in Helena.
“The way we do dialysis in this country, no one would be saying, ‘this is the way we should be doing things.’ No one would,” LaClair says.
When he came to St. Peter’s five years ago, LaClair decided he was going to do things differently. He was going to encourage as many of his patients as possible to dialyze at home.
Listen to the complete story online at Montana Public Radio.